U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H18N2O.ClH
Molecular Weight 314.809
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEMEXIPTILINE HYDROCHLORIDE

SMILES

Cl.CNCCON=C1C2=CC=CC=C2C=CC3=CC=CC=C13

InChI

InChIKey=MZTHMUGFMPRTIK-UHFFFAOYSA-N
InChI=1S/C18H18N2O.ClH/c1-19-12-13-21-20-18-16-8-4-2-6-14(16)10-11-15-7-3-5-9-17(15)18;/h2-11,19H,12-13H2,1H3;1H

HIDE SMILES / InChI

Description

Demexiptiline (Tinoran, Deparon) is a tricyclic antidepressant, noradrenergic drug. It is a norepinephrine reuptake inhibitor. Deparon was used in France for the treatment of depression.

Originator

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice.
1993
Patents

Patents

CA2834262A1
2
EP2701684B1
2

Sample Use Guides

In Vivo Use Guide
Curator's Comment: LD50 in rats (mg/kg): 330 orally, 25 i.v. https://www.drugfuture.com/chemdata/demexiptiline.html
Treatment of depression: 50-75mg
Route of Administration: Unknown
Name Type Language
DEMEXIPTILINE HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
5H-DIBENZO(A,D)CYCLOHEPTEN-5-ONE O-(2-(METHYLAMINO)ETHYL)OXIME HYDROCHLORIDE
Systematic Name English
DEMEXIPTILINE HCL
Common Name English
DEMEXIPTILINE HYDROCHLORIDE [MART.]
Common Name English
DEPARON
Brand Name English
DEMEXIPTILINE HYDROCHLORIDE [MI]
Common Name English
Demexiptiline hydrochloride [WHO-DD]
Common Name English
LM-2909
Code English
Code System Code Type Description
SMS_ID
100000087730
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
PUBCHEM
28875
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
CAS
18059-99-9
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
FDA UNII
ULT22161QA
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
EVMPD
SUB01581MIG
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
ECHA (EC/EINECS)
241-969-1
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
MERCK INDEX
m1105
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY Merck Index
EPA CompTox
DTXSID10939352
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
DRUG BANK
DB08998
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
MESH
C033781
Created by admin on Fri Dec 15 17:32:21 GMT 2023 , Edited by admin on Fri Dec 15 17:32:21 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of DEMEXIPTILINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966